Lipe & Dalton
BSX icon

Lipe & Dalton’s Boston Scientific BSX Stock Holding History

Lipe & Dalton’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$493K Hold
11,300
– – 0.23% 58
2026
Q2 		$482K Buy
+11,300
New +$614K 0.22% 58

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
AMF Tjänstepension
AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return
ZWJ Investment Counsel
ZWJ Investment Counsel Atlanta, Georgia $3.24B AUM 31.6% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Gateway Investment Advisers
Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return
Gradient Investments
Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Lipe & Dalton's BSX Position: Q3 2026 in Review

Lipe & Dalton held its Boston Scientific (BSX) position steady in Q3 2026 at 11,300 shares worth $493K. The position accounts for 0.23% of the portfolio, ranked #58.

Lipe & Dalton first reported a position in BSX in Q2 2026 and has held it in 2 quarters since. 335 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Lipe & Dalton held 11,300 shares of Boston Scientific worth $493K as of Q3 2026.
  • Lipe & Dalton left its Boston Scientific share count unchanged in Q3 2026.
  • Boston Scientific made up 0.23% of Lipe & Dalton's portfolio in Q3 2026, its #58 holding.
  • Lipe & Dalton first reported a position in Boston Scientific in Q2 2026 and has held it in 2 quarters since.
  • 335 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Lipe & Dalton's 13F filing for Q3 2026, filed 15 Oct 2026.